# FDA Inspection 1168927 - Jacek C. Szepietowski - March 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/jacek-c-szepietowski/fbdb0b16-846d-44d6-9478-fe087cece7b8
Source feed: FDA_Inspections

> FDA Inspection 1168927 for Jacek C. Szepietowski on March 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168927
- Company Name: Jacek C. Szepietowski
- Inspection Date: 2022-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028400 - 2017-08-11](https://www.keypedia.com/records/fda_inspections/jacek-c-szepietowski/87f90d93-edc9-4c44-b749-8e8d52c3061d)
- [FDA Inspection 885302 - 2014-05-08](https://www.keypedia.com/records/fda_inspections/jacek-c-szepietowski/2fe9525d-4d01-4ea2-955d-9ca1f7eba5c8)

Company: https://www.keypedia.com/companies/jacek-c-szepietowski/8ac92efb-a233-4afe-8186-c066a9acacf0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c